Literature DB >> 10971521

Expression of vascular endothelial growth factor by synovial fluid neutrophils in rheumatoid arthritis (RA).

T Kasama1, K Kobayashi, N Yajima, F Shiozawa, Y Yoda, H T Takeuchi, Y Mori, M Negishi, H Ide, M Adachi.   

Abstract

Most of the leucocytes infiltrating rheumatoid synovial fluid (SF) are neutrophils capable of producing a variety of inflammatory mediators known to contribute significantly to the disease process during active RA. In the present study, we investigated the contribution made by SF neutrophils to the elevated levels of vascular endothelial growth factor (VEGF) seen in rheumatoid SF. Rheumatoid SF neutrophils were found to contain significantly larger amounts of both VEGF protein and its mRNA than peripheral blood neutrophils from either RA patients or healthy controls. Levels of cell-associated VEGF were well correlated with free VEGF in SF, which was significantly higher than in SF from osteoarthritis patients. Levels of SF neutrophil-associated VEGF also correlated with RA disease activity and cell surface integrin expression. Thus, SF neutrophil-associated VEGF may be considered an indicator of both local and systemic inflammation of RA, contributing to the neovascularization seen during RA synovitis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10971521      PMCID: PMC1905727          DOI: 10.1046/j.1365-2249.2000.01272.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

Review 1.  Molecular and biological properties of the vascular endothelial growth factor family of proteins.

Authors:  N Ferrara; K Houck; L Jakeman; D W Leung
Journal:  Endocr Rev       Date:  1992-02       Impact factor: 19.871

Review 2.  Poly's lament: the neglected role of the polymorphonuclear neutrophil in the afferent limb of the immune response.

Authors:  A R Lloyd; J J Oppenheim
Journal:  Immunol Today       Date:  1992-05

3.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

4.  Vascular endothelial growth factor is a secreted angiogenic mitogen.

Authors:  D W Leung; G Cachianes; W J Kuang; D V Goeddel; N Ferrara
Journal:  Science       Date:  1989-12-08       Impact factor: 47.728

5.  Vascular permeability factor, an endothelial cell mitogen related to PDGF.

Authors:  P J Keck; S D Hauser; G Krivi; K Sanzo; T Warren; J Feder; D T Connolly
Journal:  Science       Date:  1989-12-08       Impact factor: 47.728

6.  Peripheral blood mononuclear cells from patients with rheumatoid arthritis spontaneously secrete vascular endothelial growth factor (VEGF): specific up-regulation by tumour necrosis factor-alpha (TNF-alpha) in synovial fluid.

Authors:  M J Bottomley; N J Webb; C J Watson; P J Holt; A J Freemont; P E Brenchley
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330

7.  Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor.

Authors:  D Maglione; V Guerriero; G Viglietto; P Delli-Bovi; M G Persico
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

8.  Markers of inflammatory activation: upregulation of complement receptors CR1 and CR3 on synovial fluid neutrophils from patients with inflammatory joint disease.

Authors:  A D Crockard; J M Thompson; S J McBride; J D Edgar; T A McNeill; A L Bell
Journal:  Clin Immunol Immunopathol       Date:  1992-11

9.  Cloning and sequencing of a deoxyribonucleic acid copy of glyceraldehyde-3-phosphate dehydrogenase messenger ribonucleic acid isolated from chicken muscle.

Authors:  A Dugaiczyk; J A Haron; E M Stone; O E Dennison; K N Rothblum; R J Schwartz
Journal:  Biochemistry       Date:  1983-03-29       Impact factor: 3.162

10.  Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration.

Authors:  M Clauss; M Gerlach; H Gerlach; J Brett; F Wang; P C Familletti; Y C Pan; J V Olander; D T Connolly; D Stern
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

View more
  18 in total

1.  Differential angiogenic regulation of experimental colitis.

Authors:  John H Chidlow; Will Langston; James J M Greer; Dmitry Ostanin; Maisoun Abdelbaqi; Jeffery Houghton; Annamalai Senthilkumar; Deepti Shukla; Andrew P Mazar; Matthew B Grisham; Christopher G Kevil
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

2.  Correlation between circulating VEGF levels and disease activity in rheumatoid arthritis: a meta-analysis.

Authors:  Young Ho Lee; Sang-Cheol Bae
Journal:  Z Rheumatol       Date:  2018-04       Impact factor: 1.372

3.  Receptor binding mode and pharmacological characterization of a potent and selective dual CXCR1/CXCR2 non-competitive allosteric inhibitor.

Authors:  R Bertini; L S Barcelos; A R Beccari; B Cavalieri; A Moriconi; C Bizzarri; P Di Benedetto; C Di Giacinto; I Gloaguen; E Galliera; M M Corsi; R C Russo; S P Andrade; M C Cesta; G Nano; A Aramini; J C Cutrin; M Locati; M Allegretti; M M Teixeira
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

4.  VEGF Profile in Early Undifferentiated Arthritis Cohort.

Authors:  Regina Sakalyte; Loreta Bagdonaite; Sigita Stropuviene; Sarune Naktinyte; Algirdas Venalis
Journal:  Medicina (Kaunas)       Date:  2022-06-20       Impact factor: 2.948

5.  Treatment with anti-NAP monoclonal antibody reduces disease severity in murine model of novel angiogenic protein-induced or ovalbumin-induced arthritis.

Authors:  N B Nataraj; J Krishnamurthy; B P Salimath
Journal:  Clin Exp Immunol       Date:  2013-02       Impact factor: 4.330

Review 6.  Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis.

Authors:  Zhiheng He; Andrew Bateman
Journal:  J Mol Med (Berl)       Date:  2003-08-19       Impact factor: 4.599

7.  Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy.

Authors:  Norihiro Nishimoto; Nobuyuki Miyasaka; Kazuhiko Yamamoto; Shinichi Kawai; Tsutomu Takeuchi; Junichi Azuma; Tadamitsu Kishimoto
Journal:  Mod Rheumatol       Date:  2008-11-01       Impact factor: 3.023

Review 8.  VEGF and imaging of vessels in rheumatoid arthritis.

Authors:  Peter C Taylor
Journal:  Arthritis Res       Date:  2002-05-09

Review 9.  Angiogenesis in rheumatoid arthritis.

Authors:  Ewa M Paleolog
Journal:  Arthritis Res       Date:  2002-05-09

10.  Expression and regulation of CCL18 in synovial fluid neutrophils of patients with rheumatoid arthritis.

Authors:  Judith Auer; Markus Bläss; Hendrik Schulze-Koops; Stefan Russwurm; Thomas Nagel; Joachim R Kalden; Martin Röllinghoff; Horst Ulrich Beuscher
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.